Health disparities in transplantation: Focus on the complexity and challenge of renal transplantation in African Americans

Medical Clinics of North America

Volumn 89, Issue 5, 2005, Pages 1003-1031

  Young, Carlton J ^a   Kew, Clifton ^b  

^a Kentucky   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYTOCHROME P450 3A; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; MAJOR HISTOCOMPATIBILITY ANTIGEN; TACROLIMUS;

AFRICAN AMERICAN; ANTIGEN PRESENTING CELL; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; DRUG ABSORPTION; DRUG CLEARANCE; ETHNIC GROUP; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HEALTH CARE; HUMAN; HYPERTENSION; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVING DONOR; LYMPHOCYTE PROLIFERATION; ORGAN DONOR; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SENSITIZATION; SOCIOECONOMICS; T LYMPHOCYTE; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME;

AFRICAN AMERICANS; ATTITUDE OF HEALTH PERSONNEL; DIABETES MELLITUS, TYPE 2; DONOR SELECTION; GRAFT SURVIVAL; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; PATIENT EDUCATION; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 23944464670     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2005.05.002     Document Type: Review

References (143)

1. R.A. Wolf, A.V. Ashby, and E.I. Milford Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant New Engl J Med 341 1999 725 732
2. G. Opelz, M.R. Mickey, and P.I. Terasaki Influence of race on kidney transplant survival Transplant Proc 9 1977 137 142
3. P.W. Eggers Effect of transplantation on the Medicare end stage renal disease program New Engl J Med 318 1988 223 229
4. R.E. Qualheim, S.G. Rostand, and K.A. Kirk Changing patterns of end stage renal disease due to hypertension Am J Kidney Dis 18 1991 336 343
5. S.G. Rostand US minority groups and end-stage renal disease: a disproportionate share Am J Kidney Dis 19 1992 411 413
6. United States Renal Data System Excerpts from the USRDS 1999 annual data report Am J Kidney Dis 34 Suppl 1 1999 S1 176
7. L. Agodoa Lessons from chronic renal diseases in African American Americans: treatment implications Ethn Dis 13 Suppl 2 2003 118 124
8. US Renal Data System USRDS 2003 annual data report: atlas of end-stage renal disease in the United States 2003 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda (MD)
9. W.D. Hall, J.W. Kusek, and K.A. Kirk Short-term effects of blood pressure control and antihypertensive drug regimen on glomerular filtration rate: the African-American Study of Kidney Disease and Hypertension Pilot Study Am J Kidney Dis 29 1997 720 728
10. E.D. Crook, J. Harris, and B. Oliver End-stage renal disease owing to diabetic nephropathy in Mississippi: an examination of factors influencing renal survival in a population prone to late referral J Invest Med 49 3 2001 284 291
11. J.S. Krop, J. Coresh, and L.E. Chamblers A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs. whites with diabetes: the Atherosclerosis Risk in Communities study Arch Intern Med 159 5 1999 1777 1783
12. M.J. Klag, J. Stamler, and F.L. Brancat End-stage renal disease in African-American and white men: 16-year MRFIT findings JAMA 277 16 1997 1293 1298
13. J. Coresh, G.K. Wei, and G. McQuillian Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the Third National Health and Nutrition Examination Survey (1988-1994) Arch Intern Med 161 2001 1207 1216
14. C.E. Grim, J.P. Henry, and H. Myers High blood pressure in blacks: salt, slavery, survival, stress, and racism J.H. Laragh B.M. Brenner Hypertension: pathophysiology, diagnosis, and management 1995 Raven Press New York 171 207
15. US Renal Data System. USRDS 2001 annual data report. Bethesda (MD): National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2001.
16. V.I. Burt, P. Whelton, and E.J. Roccalla Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination survey 1988-1991 Hypertension 25 1995 305 313
17. United Network for Organ Sharing UNOS 1999 annual report of the US Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network. Transplant data: 1994-1998 1999 United Network for Organ Sharing Richmond (VA)
18. A. Fogo, J.A. Breyer, and M.C. Smith and the AASK Pilot Study Investigators. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African-American Study of Kidney Diseases (AASK) Trial Kidney Int 51 1997 244 252
19. A. Fogo, J.A. Breyer, and M.C. Smith and AASK Pilot Study Investigators Renal histopathology in US African Americans with presumed hypertensive nephrosclerosis Nephrology 4 1998 S54 S58
20. S. Bergman, B.O. Key, and K.A. Kirk Kidney disease in the first-degree relatives of African Americans with hypertensive end-stage renal disease Am J Kidney Dis 27 1996 341 346
21. D.G. Warnock Low renin hypertension in the next millennium Semin Nephrol 20 2000 40 46
22. J.H. Summerson, R.A. Bell, and J.C. Konen Racial differences in the prevalence of microalbuminuria in hypertension Am J Kidney Dis 26 1995 577 579
23. H.J. Geiger Race and health care - an American dilemma New Engl J Med 335 1996 815 816
24. M.E. Gornick, P.W. Eggers, and T.W. Reilly Effects of race and income on mortality and use of services among Medicare beneficiaries New Engl J Med 335 1996 791 799
25. S.D. Schlessinger, M.R. Tankersley, and J.J. Curtis Clinical documentation of end-stage renal disease due to hypertension Am J Kidney Dis 23 1994 655 660
26. E.A. Friedman, B.G. Delano, and K.M.H. Butt Pragmatic realities in uremia therapy N Engl J Med 298 1978 368 371
27. B.L. Kasiske, D. Cohen, and M.R. Lucey Payment for immunosuppression after organ transplantation JAMA 283 2000 2445 2450
28. A. Laupacis, P. Keown, and N. Pus A study of the quality of life and cost-utility of renal transplantation Kidney Int 50 1996 235 242
29. A.O. Ojo, F.K. Port, and R.A. Wolfe Comparative mortality risks of chronic dialysis and cadaveric transplantation in black end-stage renal disease patients Am J Kidney Dis 24 1994 59 64
30. United Network for Organ Sharing 1998 Annual report - Scientific Registry 1999 United Network for Organ Sharing Richmond (VA)
31. US Renal Data System USRDS 2002 annual data report 2002 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda (MD)
32. M. Thamer, W. Hwang, and N.E. Fink US nephrologists' attitudes towards renal transplantation: results from a national survey Transplantation 71 2 2001 281 288
33. J.M. Soucie, J.F. Neylan, and W. McClellan Race and sex differences in the identification of candidates for renal transplantation Am J Kidney Dis 19 1992 414 419
34. J.Z. Ayanian, P.D. Clearly, and J.H. Keogh Physician's beliefs about racial differences in referral for renal transplantation Am J Kidney Dis 43 2 2004 350 357
35. J.Z. Ayanian, P.D. Cleary, and J.S. Weissman The effect of patients' preferences on racial differences in access to renal transplantation New Engl J Med 341 1999 1661 1669
36. A.M. Epstein, J.Z. Ayanian, and J.H. Keogh Racial disparities in access to renal transplantation N Engl J Med 343 21 2000 1537 1544
37. Kallich JD, Adams JL, Barton PL, et al. Access to cadaveric kidney transplantation. Santa Monica (CA): Rand/UCLA/Harvard Center for Health Care Financing Policy Research; 1993.
38. P.P. Garg, M. Diener-West, and N.R. Powe Reducing racial disparities in transplant activation: whom should we target? Am J Kidney Dis 37 5 2001 921 931
39. M.R. Tankersley, R.S. Gaston, and J.J. Curtis The living donor process in kidney transplantation: influence of race and co-morbidity Transplant Proc 29 1997 3722 3723
40. B.L. Kasiske, W. London, and M. Ellison Race and socioeconomic factors influencing early placement on the kidney transplant waiting list J Am Soc Nephrol 9 1998 2142 2147
41. H.U. Meier-Kriesche, F.K. Port, and A.O. Ojo Effect of waiting time on renal transplant outcome Kidney Int 58 2000 1311 1317
42. R.H. Kerman, P.M. Kimball, and C.T. Van Buren Influence of race on crossmatch outcome and recipient eligibility for transplantation Transplantation 53 1992 64 67
43. D.J. Norman, M.D. Ellison, and T.J. Breen Cadaveric kidney allocation in the United States: a critical analysis of the point system Transplant Proc 27 1995 800
44. V.A. Lazda, and M.E. Blaesing Is allocation of kidneys on basis of HLA match equitable in multiracial populations? Transplant Proc 21 1989 1415 1416
45. V.A. Lazda The impact of HLA frequency differences in races on the access to optimally HLA-matched cadaver renal transplants Transplantation 53 1992 352 357
46. B. Barger, T.W. Shroyer, and S.L. Hudson The impact of the UNOS mandatory sharing policy on recipients of the black and white races: experience at a single renal transplant center Transplantation 53 1992 770 774
47. S.K. Takemoto, and P.I. Terasaki Twelve years' experience with national sharing of HLA matched cadaveric kidneys for transplantation New Engl J Med 343 15 2000 1078 1084
48. Y. Hata, M. Ozawa, and S.K. Takemoto HLA matching J.M. Cecka P.I. Terasaki Clinical transplants 1996 1997 UCLA Tissue Typing Laboratory Los Angeles (CA) 381 396
49. V. Scantlebury, D. Gjertson, and M. Eliasziw Effect of HLA mismatch in African Americans Transplantation 65 1998 586 588
50. S. Takemoto, P.I. Terasaki, and D.W. Gjertson Equitable allocation of HLA-compatible kidneys for local pools and for minorities New Engl J Med 331 1994 760 764
51. S. Takemoto, P.I. Terasaki, and J.M. Cecka For the UNOS Renal Transplant Registry. Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors New Engl J Med 327 1992 834 839
52. J.M. Cecka The UNOS Scientific Renal Transplant Registry J.M. Cecka P.I. Terasaki Clinical transplants 1998 1999 UCLA Tissue Typing Laboratory Los Angeles (CA) 1 16
53. D.W. Gjertson Short- and long-term effects of HLA matching P.I. Terasaki Clinical transplants 1989 1989 UCLA Tissue Typing Laboratory Los Angeles (CA) 353 360
54. D.W. Gjertson Two-factor reference tables for renal transplantation J.M. Cecka P.I. Terasaki Clinical transplants 1995 1996 UCLA Tissue Typing Laboratory Los Angeles (CA) 433 485
55. P.J. Held, B.D. Kahan, and L.G. Hunsicker The impact of HLA mismatches on the survival of first cadaveric kidney transplants New Engl J Med 331 1994 765 770
56. H.I. Feldman, D.A. Roth, and I. Fazio National kidney allograft sharing: a decision analysis Transplantation 64 1997 80 88
57. R.S. Gaston, I. Ayres, and L.G. Dooley Racial equity in renal transplantation: the disparate impact of HLA-based allocation JAMA 270 1993 1352 1356
58. E.R. Scaife, M.C. Mone, and J. Shelby Characteristics of kidneys offered as paybacks in the zero-antigen mismatch sharing policy Transplant Proc 29 1997 3441 3443
59. United Network for Organ Sharing. Point change results from UNOS study. Richmond (VA): United Network for Organ Sharing; Update 1994; Dec:18.
60. F.L. Delmonico, E.L. Milford, and J. Goguen A novel United Network for Organ Sharing region kidney allocation plan improves transplant access for minority candidates Transplantation 68 1999 1875 1879
61. G.M. Chertow, B.M. Brenner, and H.S. Mackenzie Non-immunologic predictors of chronic renal allograft failure: data from the United Network for Organ Sharing Kidney Int 52 Suppl 52 1995 S48 S51
62. P.F. Halloran, A. Melk, and C. Barth Rethinking chronic allograft nephropathy: the concept of accelerated senescence J Am Soc Nephrol 10 1999 167 181
63. A.O. Ojo, R.A. Wolfe, and P.J. Held Delayed graft function: risk factors and implications for renal allograft survival Transplantation 63 1997 968 974
64. E.J. Schweitzer, S. Yoon, and J. Hart Increased living donor volunteer rates with a formal recipient family education program Am J Kidney Dis 29 1997 739 745
65. A. Ojo, and F.K. Port Influence of race and gender on related donor renal transplantation rates Am J Kidney Dis 22 1993 835 841
66. L.E. Ratner, L.J. Ciseck, and R.G. Moore Laparoscopic live donor nephrectomy Transplantation 60 1995 1047 1049
67. B.O. Barger, S.L. Hudson, and T.W. Shroyer Influence of race on renal allograft survival in the pre and post-cyclosporine era P.I. Terasaki Clinical transplants 1987 1987 UCLA Tissue Typing Laboratory Los Angeles (CA) 217 233
68. A.O. Ojo, F.K. Port, and P.J. Held Inferior outcome of two-haplotype matched renal transplants in blacks: role of early rejection Kidney Int 48 1995 1592 1599
69. G. Opelz, E. Pfarr, and A. Engelmann Kidney graft survival rates in black cyclosporine-treated patients Transplant Proc 21 1989 3918 3920
70. S. Katznelson, D.W. Gjertson, and J.M. Cecka The effect of race and ethnicity on kidney allograft outcome J.M. Cecka P.I. Terasaki Clinical transplants 1995 1996 UCLA Tissue Typing Laboratory Los Angeles (CA) 379 394
71. R.S. Gaston, S.L. Hudson, and M.H. Deierhoi Improved survival of primary cadaveric renal allografts in blacks with quadruple immunosuppression Transplantation 53 1992 103 109
72. J. Yuge, and J.M. Cecka The race effect P.I. Terasaki Clinical transplants 1989 1989 UCLA Tissue Typing Laboratory Los Angeles (CA) 407 415
73. G. Oplez, T. Wujciak, and E. Ritz Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study Kidney Int 53 1 1998 217 222
74. F.G. Cosio, J.J. Dillon, and M.E. Falkenhain Racial differences in renal allograft survival: the role of systemic hypertension Kidney Int 47 1995 1136 1141
75. A. Martinez-Castelao, M. Hueso, and V. Sanz treatment of hypertension after renal transplantation: long-term efficacy of verapamil, enalapril, and doxazosin Kidney Int 54 Suppl 1998 S130 S134
76. J.J. Curtis Management of hypertension Kidney Int 43 Suppl 1993 S45 S49
77. F.H. Messerli Hypertension in special populations Med Clin N Am 81 1997 1335 1345
78. M.H. Weinberger Hypertension in African Americans: the role of sodium chloride and extracellular fluid volume Semin Nephrol 16 1996 110 116
79. B. Falkner The role of cardiovascular reactivity as a mediator of hypertension in African Americans Semin Nephrol 16 1996 117 125
80. A.L. Grubbs, and A. Ergul A review of endothelin and hypertension in African Americans individuals Ethn Dis 11 2001 741 748
81. The Sixth Report of the Joint National Committee on Prevention Detection, Evaluation, and Treatment of High Blood Pressure 1997 National Institutes of Health, National Heart, Lung, and Blood Institute Bethesda (MD)
82. J.T. Wright Jr., J.W. Kusek, and R.D. Toto Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study Control Clin Trials 17 1996 3S 16S
83. L.Y. Agodoa, L. Appel, G.L. Bakris for the African-American Study of Kidney Disease and Hypertension (AASK) Study Group Effect of ramipril vs. amlodipine on renal outcomes in hypertensive nephrosclerosis. A randomized controlled trial JAMA 285 2001 2719 2728
84. J.T. Wright Jr., G. Bakris, T. Greene for the African-American Study of Kidney Disease and Hypertension Study Group Effect of blood pressure lowering and anti-hypertensive drug class on progression of hypertensive kidney disease: results of the AASK Trial JAMA 282 2001 2421 2431
85. J.S. Winston, G.C. Burns, and P.E. Klotman The human immunodeficiency virus (HIV) epidemic and HIV-associated nephropathy Semin Nephrol 18 4 1998 373 377
86. R.S. Woodward, M.A. Schnitzler, and J.A. Lowell Medicare's extended immunosuppression coverage improved graft survival [abstract] J Am Soc Nephrol 10 1999 751A
87. Anonymous. Latino Americans: the face of the future. Newsweek. July 12, 1999:50-1.
88. R.T. Schweizer, M. Rovelli, and D. Palmeri Noncompliance in organ transplant recipients Transplantation 49 1990 374 377
89. J.J. Curtis Kidney transplantation: racial or socioeconomic disparities? Am J Kidney Dis 34 1999 756 758
90. R.B. Isaacs, S. Nock, and C. Spencer Racial disparities in renal transplant outcomes Am J Kidney Dis 34 1999 706 712
91. R.H. Didlake, K. Dreyfus, and R.H. Kerman Patient non-compliance: a major cause of late graft failure in cyclosporine-treated renal transplants Transplant Proc 20 1988 63
92. R.S. Gaston, S.L. Hudson, and M. Ward Late renal allograft loss: non-compliance masquerading as chronic rejection Transplant Proc 31 Suppl 4A 1999 21S
93. R.S.N. Kalil, K.L. Heiem-Duthoy, and B.L. Kasiski Patients with low income have reduced renal allograft survival Am J Kidney Dis 20 1 1992 63 69
94. D.E. Butkus, A.L. Dottes, and E. Meydrech Effect of poverty and other socioeconomic variables on renal allograft survival Transplantation 72 2 2002 261 266
95. R.B. Isaacs, A. Conners, and S. Nock Noncompliance in living-related donor renal transplantation: the United Network of Organ Sharing Experience Transplantation Proc 31 Suppl 4A 1999 19S 20S
96. C.E. Sanders, J.J. Curtis, and B.A. Julian Tapering or discontinuing cyclosporine for financial reasons - a single center experience Am J Kidney Dis 21 1993 9 15
97. C.E. Sanders, B.A. Julian, and R.S. Gaston Benefits of continued cyclosporine through an indigent drug program Am J Kidney Dis 28 1996 572 577
98. R.S. Gaston Evolution of Medicare policy involving transplantation and immunosuppressive medications: past developments and future directions M.J. Field R.L. Lawrence L. Zwanziger Extending Medicare coverage for preventive and other services 2000 National Academy Press Washington, DC 310 328
99. J.D. Oliver, C.M. Yuan, and P.G. Welch Renal allograft survival is independent of race in the US Military Health Care System [abstract] J Am Soc Nephrol 10 1999 741A
100. O.E. Emovon, J.A.C. King, and C.O. Holt Effect of cyclosporine pharmacokinetics on renal allograft outcome in African Americans Clin Transplant 17 2003 206 211
101. International Neoral Renal Transplantation Study Group Randomized, international study of cyclosporine microemulsion absorption profiling in renal transplantation with basiliximab immunoprophylaxis Am J Transplant 2 2002 157 166
102. J.F. Neylan Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine Transplantation 65 4 1998 515 523
103. P.A. Andrews, M. Sen, and R.W. Chang Racial variations in dosage requirements of tacrolimus [letter] Lancet 348 1996 1446
104. Heifets M, Cooney G, Shaw L, et al., Ethnic differences in tacrolimus pharmacokinetics in renal transplant candidates. 1996 Annual Meeting of the American Society of Transplant Physicians. Abstracts-On-Disk: K-KT-099.
105. I.A.M. Macphee, S. Fredericks, and T. Tai Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome P4503A5 and p-glycoprotein correlate with dose requirement Transplantation 74 11 2002 1486 1489
106. E. Thervet, D. Anglicheau, and B. King Impact of cytochrome P450 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients Transplantation 76 8 2003 1233 1235
107. N. Tsuchiya, S. Satoh, and H. Tada Influence of CYP3A5 and MDR1(ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients Transplantation 78 8 2004 1182 1187
108. M.S. Leffell, A.G. Steinberg, and W.B. Bias The distribution of HLA antigens and phenotypes among donors and patients in the UNOS registry Transplantation 58 1994 1119 1130
109. Y.C. Zhou, J.M. Cecka, and P.I. Terasaki Effect of race on kidney transplants P.I. Terasaki Clinical transplants 1990 1991 UCLA Tissue Typing Laboratory Los Angeles (CA) 447 459
110. G. Oplez, J. Mytilineos, and S. Scherer Influence of HLA matching and DNA typing on kidney and heart transplant survival in black recipients Transplant Proc 29 1997 3333 3335
111. F.K. Port, V.B. Ashby, and A.B. Leichtman Eliminating points for HLA-B similarity increased allocation to minority, pediatric, sensitized, and zero MM candidates [abstract] American Journal of Transplantation 4 8 2004 414 441
112. L.M. Rebellato, A.N. Arnold, and K.M. Bozik HLA matching and the united network for organ sharing allocation system: impact of HLA matching on African-American recipients of cadaveric kidney transplants Transplantation 74 11 2002 1634 1636
113. P.L. Mottram, W.R. Han, and L.J. Purcell Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-γ in long-surviving mouse heart allografts after brief CD-4 monoclonal antibody therapy Transplantation 59 1995 559 565
114. A. Minguela, A. Torio, and L. Marin Implication of Th1, Th2, and Th3 cytokines in liver graft acceptance Transplant Proc 31 1993 519 520
115. A.G. Wilson, J.A. Symons, and T.L. McDowell Effects of a polymorphism in the human tumor necrosis factor a (TNF-α) promoter in transcriptional activation Proc Natl Acad Sci U S A 94 1997 3195 3199
116. S.V. Fuggle, and D.D. Koo Cell adhesion molecules in clinical renal transplantation Transplantation 65 1998 763 769
117. P.F. Halloran, A.P. Broski, and T.D. Batiuk the molecular immunology of acute rejection: an overview Transplant Immunol 1 1993 3 27
118. M. Suthanthiran Acute rejection of renal allografts; mechanistic insights and therapeutic options Kidney Int 51 1997 1289 1304
119. A.J. Bathgate, V. Pravica, and C. Perry The effect of polymorphism in tumor necrosis factor-α, interleukine-10, and transforming growth factor-β1 genes in acute hepatic allograft rejection Transplantation 69 2000 1514 1517
120. D. Sankaran, A. Asderakis, and S. Asharf Cytokine gene polymorphisms predict acute graft rejection following renal transplantation Kidney Int 56 1999 281 288
121. I.V. Hutchinson, V. Pravica, and P. Sinnott Genetic regulation of cytokine synthesis; consequences for acute and chronic organ allograft rejection Graft 56 2000 281
122. M. Suthanthiran The importance of genetic polymorphisms in renal transplantation Curr Opin Urol 10 2 2000 71 75
123. A. Asderakis, D. Sanaran, and P. Dyer Association of polymorphisms in the human interferon-γ and interleukin-10 gene with acute and chronic kidney transplant outcome. The cytokine effect on transplantation Transplantation 71 2001 674 678
124. I.V. Hutchinson, D. Turner, and D. Sankaran Cytokine genotypes in allograft rejection: guidelines for immunosuppression Transplant Proc 30 1998 3991 3992
125. A.G. Wilson, F.S. di Giovine, and A.I. Blakemore Single base polymorphism in the human tumor necrosis factor-α (TNF-α) gene detectable by Ncol restriction of PCR product Hum Mol Genet 1 5 1992 353
126. S. John, D. Turner, and R. Donn Two novel bi-allelic polymorphisms in the IL-2 gene Eur J Immunogenet 25 1998 419 420
127. D.O. McDaniel, W.H. Barber, and C. Nguyan Combined analysis of cytokine genotype polymorphism and the level of expression with allograft function in African-American renal transplant patients Transplant Immunol 11 2002 107 119
128. A. Hutchings, W.M. Purcell, and M.R. Benfield Increased co-stimulatory responses in African American kidney allograft recipients Transplantation 71 5 2001 692 695
129. H. Azuma, A. Chandraker, and K. Nedeau Blockade of T-cell co-stimulation prevents development of experimental chronic renal allograft rejection Proc Natl Acad Sci U S A 93 22 1996 12439 12444
130. T.C. Pearson, D.Z. Alexander, and M. Corbascio Analysis of the B7 co-stimulatory pathway in allograft rejection Transplantation 63 10 1997 1463
131. R.H. Kerman, P.M. Kimball, and C.T. Van Buren Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients Transplantation 51 1991 338 342
132. J.F. Neylan Immunosuppressive therapy in high-risk transplant patients: dose-dependent efficacy of mycophenolate mofetil in African-American renal allograft recipients Transplantation 64 1997 1277 1282
133. H.U. Meier-Kriesche, A.O. Ojo, and A.B. Leichtman Effect of mycophenolate mofetil on long-term outcomes in African American renal transplant recipients J Am Soc Nephrol 11 2000 2366 2370
134. D.E. Hricik, H.A. Anton, and T.C. Knauss Outcomes of African American kidney transplant recipients with sirolimus, tacrolimus, and corticosteroids Transplantation 74 2 2002 189 193
135. A.C. Klassen, A.G. Hall, and B. Saksvig Relationship between patient's perceptions of disadvantage and discrimination and listing for kidney transplantation Am J Public Health 92 5 2002 811 817
136. L. Cooper-Patrick, J.J. Gallo, and J.J. Gonzales Race, gender, and partnership in the patient-physician relationship JAMA 282 1999 583 589
137. K.A. Sculman, J.A. Berlin, and W. Harless The effect of race and sex on physician's recommendations for cardiac catheterization New Engl J Med 340 1999 618 626
138. A.A. Zachary, W.E. Braun, and J.M. Hayes Effect of HLA matching on organ distribution among whites and African Americans Transplantation 57 1994 1115 1119
139. A.M. Harper, J.D. Rosendale, and M.A. McBride The UNOS OPTN waiting list and donor registry J.M. Cecka P.I. Terasaki Clinical transplants 1998 1999 UCLA Tissue Typing Laboratory Los Angeles (CA) 73 90
140. C. Callender, B. Burston, and C. Yeager A national minority transplant program for increasing donation rates Transplant Proc 29 1997 1482 1483
141. D.E. Hricik, C.C. Whalen, and J. Lautman Withdrawal of steroids after renal transplantation-clinical predictors of outcome Transplantation 53 1992 41 45
142. A. Matas, and M. Ewell Prednisone withdrawal in kidney transplant recipients on CsA/MMF-a prospective, randomized study [abstract] Transplantation 67 1999 S269
143. H. Koyama, J.M. Cecka, and P.I. Terasaki Kidney transplants in black recipients: HLA matching and other factors affecting long-term graft survival Transplantation 57 1994 1064 1068